Summary
[Arg6,D-Trp7,9,NmePhe8]-substance P (6–11) (antagonist G) is a novel class of anti-cancer agent that inhibits small-cell lung cancer (SCLC) cell growth in vitro and in vivo and is entering phase II clinical investigation for the treatment of SCLC. Although antagonist G blocks SCLC cell growth (IC50 = 24.5 ± 1.5 and 38.5 ± 1.5 μM for the H69 and H510 cell lines respectively), its exact mechanism of action is unclear. This study shows that antagonist G stimulates apoptosis as assessed by morphology (EC50 = 5.9 ± 0.1 and 15.2 ± 2.7 μM for the H69 and H510 cell lines respectively) and stimulates c-jun-N-terminal kinase (JNK) activity in SCLC cells (EC50 = 3.2 ± 0.1 and 15.2 ± 2.7 μM). This activity is neuropeptide-independent, but dependent on the generation of reactive oxygen species (ROS) and is inhibited by the free radical scavenger n-acetyl cysteine. Furthermore, antagonist G itself induces inflammation (59% increase in oedema volume compared to control) and potentiates (by 35–40%) bradykinin-induced oedema formation in vivo. In view of these results we show that, as well as acting as a ‘broad-spectrum’ neuropeptide antagonist, antagonist G stimulates basal G-protein activity in SCLC cell membranes (81 ± 12% stimulation at 10 μM), thereby displaying a unique ability to stimulate certain signal transduction pathways by activating G-proteins. This novel activity may be instrumental for full anti-cancer activity in SCLC cells and may also account for antagonist G activity in non-neuropeptide-dependent cancers.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Armstrong, R. A., Marr, C. & Jones, R. L. (1995). Characterization of the EP-receptor mediating dilatation and potentiation of inflammation in rabbit skin. Prostaglandins 49: 205–224.
Althoefer, H., Eversole-Cire, P. & Simon, M. I. (1997). Constitutively active Galphaq and Galpha13 trigger apoptosis through different pathways. J Biol Chem 272: 24380–24386.
Blumer, K. J. & Johnson, G. L. (1994). Diversity in function and regulation of MAP kinase pathways. Trends Biochem Sci 19: 236–240.
Brain, S. D. & Williams, T. J. (1985). Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol 86: 855–860.
Bush, R. S., Jenkin, R. D. T., Allt, W. E. C., Beale, F. A., Bean, H., Dembo, A. J. & Pringle, J. F. (1978). Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37: 302–306.
Butterfield, L., Storey, B., Maas, L. & Heasley, L. E. (1997). c-jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J Biol Chem 272: 10110–10116.
Buttke, T. M. & Sandstrom, P. A. (1994). Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7–11.
Chen, Y., Meyer, C. F. & Tan, T. (1996). Persistent activation of c-jun N-terminal kinase 1 (JNK1) in γ radiation-induced apoptosis. J Biol Chem 271: 631–634.
Coso, O. A., Chiáriello, M., Kalinec, G., Kyriakis, J. M., Woodgett, J. & Gutkind, J. S. (1995a). Transforming G protein coupled receptors potently activate JNK (SAPK). J Biol Chem 270: 5620–5624.
Coso, O. A., Chiariello, M., Yu, J. C., Teramoto, H., Crespo, P., Xu, N., Miki, T. & Gitkind, J. S. (1995b). The small GTP binding proteins racl and cdc42 regulate the activity of the JNK/SAPK signalling pathway. Cell 81: 1137–1146.
Cunnick, J. M., Dorsey, J. F., Standley, T., Turkson, J., Kraker, A. J., Fry, D. W., Jove, R. & Wu, J. (1998). Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway. J Biol Chem 273: 14468–14475.
Cuttitta, F., Carney, J., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A. & Minna, J. D. (1985). Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316: 823–826.
Everard, M. J., Macauley, V. M., Miller, J. L. & Smith, I. E. (1992). In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth. Br J Cancer 65: 388–392.
Freissmuth, M., Boehm, S., Beindl, W., Nickel, P., Ijzerman, A. P., Hohenegger, M. & Nanoff, C. (1996). Suramin analogues as subtype-selective G protein inhibitors. Mol Pharmacol 49: 602–611.
Gohla, A., Harhammer, R. & Schulz, G. (1998). The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho. J Biol Chem 273: 4653–4659.
Heasley, L. E., Storey, B., Fanger, G. R., Butterfield, L., Zamarripa, J., Blumberg, D. & Maue, R. A. (1996). GTPase-deficient Gα16 and Gαq induce PC12 cell differentiation and persistant activation of c-jun NH2-terminal kinases. Mol Cell Biol 16: 648–656.
Janssen, Y. M. W., Matalon, S. & Mossman, B. T. (1997). Differential induction of c-fos, c-jun and apoptosis in lung epithelial cells exposed to ROS or RNS. Am J Physiol 273: L789–L796.
Jarpe, M. B., Knall, C., Mitchell, F. M., Buhl, A., Duzic, E. & Johnson, G. L. (1998). [D-Arg1, D-Phe5, D D-Trp7,9, Leu11] substance P acts as a biased agonist towards neuropeptide and chemokine receptors. J Biol Chem 273: 3097–3104.
Kado-Fong, H. & Malfroy, B. (1989). Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines. J Cell Biochem 40: 431–437.
Kerr, J. F. K., Wyllie, A. H. & Currie, A. H. (1972). Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics. Br J Cancer 26: 239–245.
Kyprianou, N., English, H. F., Davidson, N. E. & Isaacs, J. T. (1992). Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162–166.
Lander, H. M., Jacovina, A. T., Davis, R. J. & Tauras, J. M. (1996). Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J Biol Chem 271: 19705–19709.
Laderoute, K. R. & Webster, K. A. (1997). Hypoxia/reoxygenation stimulates jun kinase activity through redox signalling in cardiac myocytes. Circ Res 80: 337–344.
Mitchell, F. M., Heasley, L. E., Qian, N. X., Zamarripa, J. & Johnson, G. L. (1995). Differential modulation of bombesin-stimulated phospholipase Cβ and mitogen-activated protein kinase activity by [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P. J Biol Chem 270: 8623–8628.
Moody, T. W., Pert, C. B., Gazdar, A. F., Carney, D. N. & Minna, J. D. (1981). High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science 214: 1246–1248.
Mousli, M., Beub, J., Bronner, C., Rouot, B. & Landry, Y. (1990). G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci 11: 358–362.
Mukai, H., Munekata, E. & Higashijima, T. (1992). G protein antagonists: a novel hydrophobic peptide competes with receptor for G-protein binding. J Biol Chem 267: 16237–16243.
Prasad, M. V., Dermott, J. M., Heasley, L. E., Johnson, G. L. & Dhanasekaran, N. (1995). Activation of Jun kinase/stress-activated protein kinase by GTPase-deficient mutants of Gα12 and Gα13 . J Biol Chem 270: 18655–18659.
Raff, M. C. (1992). Social controls on cell survival and cell death. Nature 356: 397–400.
Seckl, M. J., Newman, R. H., Freemont, P. S. & Rozengurt, E. (1995). Substance P-related antagonists inhibit vasopressin and bombesin but not 5′-3-O-(thio)triphosphate-stimulated inositol phosphate production in Swiss 3T3 cells. J Cell Physiol 163: 87–95.
Seckl, M. J., Higgins, T. & Rozengurt, E. (1996). [D-Arg1, D-Trp5,7,9, Leu11]substance P coordinately and reversibly inhibits bombesin and vasopressin-induced signal transduction pathways in Swiss 3T3 cells. J Biol Chem 271: 29453–29460.
Seckl, M. J., Higgins, T., Widmer, F. & Rozengurt, E. (1997). [D-Arg1, D-Trp5,7,9, Leu11] substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells. Cancer Res 57: 51–54.
Sethi, T. & Rozengurt, E. (1991a). Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecstoykinin, galanin, and neurotensin. Cancer Res 51: 3621–3623.
Sethi, T. & Rozengurt, E. (1991b). Galanin stimulates Ca2+ mobilization, inositol phosphate accumulation and clonal growth in small cell lung cancer cells. Cancer Res 51: 1674–1679.
Sethi, T., Langdon, S. P., Smyth, J. S. & Rozengurt, E. (1992). Growth of small cell lung cancer cells, stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res 52: 2737s–2742s, 1992.
Sethi, T., Rintoul, R. C., Moore, S. M., Salter, D., Choo, C., Chilvers, E. R., Dransfield, I., Donnelly, S., Strieter, R. M. & Haslett, C. (1998). Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer cell growth and drug resistance in vitro. Nature Medicine (submitted)
Seufferlein, T. & Rozengurt, E. (1996). Galanin, neurotensin and phorbol esters rapidly stimulate activation of mitogen-activated protein kinase in small cell lung cancer cells. Cancer Res 56: 5758–5764.
Smyth, J. F., Fowlie, S. M., Gregor, A., Crompton, G. K., Busutill, A., Leonard, R. C. F. & Grant, I. W. B. (1986). The impact of chemotherapy on small cell carcinoma of the bronchus. Quart J Med 61: 969–976.
Tallet, A., Chilvers, E. R., Hannah, S., Dransfield, I., Lawson, M. F., Haslett, C. & Sethi, T. (1996). Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells. Cancer Res 56: 4255–4263.
Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z. & Kolesnick, R. N. (1996). Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380: 75–79.
Weiland, T. & Jakobs, K. H. (1994). Measurement of receptor-stimulated guanosine 5′-O-(g-Thio)triphosphate binding by G Proteins. Methods Enzymol 237: 3–13.
Williams, T. J. (1979). Prostaglandin E2, prostaglandin 12 and the vascular changes of inflammation. Br J Pharmacol 65: 517–524.
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J. & Greenburg, M. E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326–1331.
Xu, Y., Bradham, C., Brenner, D. A. & Czaja, M. J. (1997). Hydrogen peroxide-induced liver cell necrosis is dependent on AP-1 activation. Am J Physiol 273: G795–G803.
Woll, P. J. & Rozengurt, E. (1988). [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of small cell lung cancer in vitro. Proc Nat Acad Sci USA 85: 1859–1863.
Woll, P. J. & Rozengurt, E. (1989). Multiple neuropeptides mobilise calcium in small cell lung cancer: effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin. Biochim Biophys Res Commun 164: 66–73.
Woll, P. J. & Rozengurt, E. (1990). A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro. Cancer Res 50: 3868–3873.
Zachary, I., Sinnet-Smith, J. W. & Rozengurt, E. (1986). Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding. J Cell Biol 102: 2211–2222.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
MacKinnon, A., Armstrong, R., Waters, C. et al. [Arg6,D-Trp7,9,NmePhe8]-substance P (6–11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism. Br J Cancer 80, 1026–1034 (1999). https://doi.org/10.1038/sj.bjc.6690458
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690458
Keywords
This article is cited by
-
Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells
Oncogene (2008)
-
Expression of V1A and GRP receptors leads to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition
British Journal of Cancer (2005)
-
Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6–11)-induced growth inhibition
British Journal of Cancer (2003)
-
Autocrine and paracrine signaling through neuropeptide receptors in human cancer
Oncogene (2001)